- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 9 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.2: 9 residues within 4Å:- Chain C: C.139, H.141, L.142, G.143, C.144, C.158, H.161, S.163, P.175
2 PLIP interactions:2 interactions with chain C,- Metal complexes: C:H.141, C:H.161
FES.16: 9 residues within 4Å:- Chain N: C.139, H.141, L.142, C.144, C.158, C.160, H.161, S.163, P.175
3 PLIP interactions:3 interactions with chain N,- Metal complexes: N:H.141, N:C.158, N:H.161
- 6 x PEE: 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.4: 12 residues within 4Å:- Chain C: A.50, N.53, A.54, F.58
- Chain D: D.36
- Chain H: H.200, M.204, K.207, M.208
- Chain I: L.235, M.239
- Ligands: PLX.12
7 PLIP interactions:1 interactions with chain I, 3 interactions with chain C, 3 interactions with chain H- Hydrophobic interactions: I:L.235, C:A.54, C:F.58, C:F.58, H:M.208
- Salt bridges: H:H.200, H:K.207
PEE.9: 21 residues within 4Å:- Chain A: E.43, V.48
- Chain I: W.29, I.91, F.94, L.95, I.97, G.98, R.99, L.101, Y.102, Y.103, W.271, F.275, I.297, M.315, Q.321, Y.324, W.325, L.331
- Ligands: CDL.1
18 PLIP interactions:17 interactions with chain I, 1 interactions with chain A- Hydrophobic interactions: I:W.29, I:W.29, I:I.91, I:I.97, I:L.101, I:Y.102, I:Y.102, I:Y.103, I:W.271, I:F.275, I:I.297, I:W.325, I:W.325, I:W.325, I:L.331
- Hydrogen bonds: I:Y.103, I:Q.321, A:E.43
PEE.14: 8 residues within 4Å:- Chain I: I.41, H.220
- Chain K: R.436, S.439, F.442, L.444
- Ligands: PLX.12, CDL.13
7 PLIP interactions:4 interactions with chain I, 3 interactions with chain K- Hydrophobic interactions: I:I.41, I:I.41
- Salt bridges: I:H.220, I:H.220
- Hydrogen bonds: K:R.436, K:S.439, K:S.439
PEE.19: 14 residues within 4Å:- Chain N: Y.49, A.50, N.53, A.54, V.55
- Chain S: H.200, M.204, K.207, M.211, M.212
- Chain T: L.81, L.235, M.239
- Ligands: PLX.17
9 PLIP interactions:1 interactions with chain T, 3 interactions with chain S, 5 interactions with chain N- Hydrophobic interactions: T:L.81, N:A.50, N:A.54, N:V.55
- Hydrogen bonds: S:H.200, S:K.207, N:Y.49, N:N.53
- Salt bridges: S:K.207
PEE.24: 18 residues within 4Å:- Chain L: S.44, V.48, F.52
- Chain T: W.29, F.94, L.95, G.98, Y.102, Y.103, L.119, M.315, Q.321, Y.324, W.325, L.331, L.332, T.335
- Ligands: CDL.15
13 PLIP interactions:13 interactions with chain T- Hydrophobic interactions: T:W.29, T:F.94, T:L.95, T:Y.102, T:L.119, T:Y.324, T:W.325, T:W.325, T:L.331, T:L.332
- Hydrogen bonds: T:Y.102, T:Y.103, T:Q.321
PEE.26: 14 residues within 4Å:- Chain N: T.44, A.48, A.51
- Chain R: A.34
- Chain T: L.9, M.10, I.13, H.220
- Chain V: S.439, F.442, L.444
- Ligands: CDL.11, PLX.17, CDL.25
10 PLIP interactions:1 interactions with chain R, 2 interactions with chain V, 3 interactions with chain N, 4 interactions with chain T- Hydrophobic interactions: R:A.34, N:T.44, N:A.48, N:A.51, T:L.9, T:I.13
- Hydrogen bonds: V:S.439, V:F.442
- Salt bridges: T:H.220, T:H.220
- 2 x HEC: HEME C(Non-covalent)
HEC.5: 22 residues within 4Å:- Chain H: V.36, C.37, C.40, H.41, N.105, A.108, L.109, P.110, P.111, L.113, I.116, R.120, Y.126, L.130, L.131, F.153, I.158, A.159, M.160, P.163, V.186
- Chain N: H.161
16 PLIP interactions:15 interactions with chain H, 1 interactions with chain N,- Hydrophobic interactions: H:V.36, H:N.105, H:A.108, H:P.110, H:P.111, H:L.113, H:I.116, H:L.130, H:L.131, H:I.158, H:V.186
- Hydrogen bonds: H:Y.126, H:A.159
- Salt bridges: H:R.120, N:H.161
- Metal complexes: H:H.41
HEC.20: 21 residues within 4Å:- Chain C: H.161
- Chain S: V.36, C.37, C.40, H.41, N.105, A.108, P.111, I.116, R.120, Y.126, V.127, L.130, L.131, F.153, I.158, A.159, M.160, P.163, V.186, L.190
19 PLIP interactions:18 interactions with chain S, 1 interactions with chain C,- Hydrophobic interactions: S:V.36, S:A.108, S:I.116, S:V.127, S:V.127, S:L.130, S:L.131, S:L.131, S:I.158, S:I.158, S:P.163, S:V.186, S:L.190
- Hydrogen bonds: S:Y.126, S:Y.126, S:A.159
- Salt bridges: S:R.120, C:H.161
- Metal complexes: S:H.41
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.7: 21 residues within 4Å:- Chain I: L.40, Q.43, I.44, G.47, L.48, L.50, A.51, R.79, H.82, A.83, A.86, T.125, G.129, L.132, P.133, F.178, H.181, F.182, P.185, F.186, Y.272
15 PLIP interactions:15 interactions with chain I,- Hydrophobic interactions: I:L.40, I:Q.43, I:I.44, I:L.48, I:L.50, I:L.50, I:T.125, I:L.132, I:F.178, I:F.182, I:F.186
- Salt bridges: I:R.79, I:R.79
- pi-Stacking: I:H.82
- Metal complexes: I:H.181
HEM.8: 18 residues within 4Å:- Chain I: W.30, G.33, S.34, L.36, F.89, L.93, H.96, I.97, R.99, S.105, Y.108, W.112, G.115, L.118, H.195, L.199, S.204, N.205
17 PLIP interactions:17 interactions with chain I,- Hydrophobic interactions: I:L.36, I:L.36, I:F.89, I:W.112, I:W.112, I:L.118, I:L.199, I:L.199
- Hydrogen bonds: I:W.30, I:G.33, I:S.34, I:N.205
- Salt bridges: I:H.96, I:R.99, I:R.99
- Metal complexes: I:H.96, I:H.195
HEM.22: 19 residues within 4Å:- Chain T: L.40, Q.43, I.44, G.47, L.48, A.51, I.65, R.79, H.82, A.83, A.86, F.89, G.129, L.132, F.178, H.181, F.182, P.185, Y.272
15 PLIP interactions:15 interactions with chain T,- Hydrophobic interactions: T:L.40, T:Q.43, T:Q.43, T:I.44, T:A.51, T:A.86, T:F.89, T:F.89, T:L.132, T:L.132, T:F.178, T:F.182
- Salt bridges: T:R.79, T:R.79
- Metal complexes: T:H.181
HEM.23: 19 residues within 4Å:- Chain T: W.30, G.33, S.34, L.36, G.37, F.89, L.93, H.96, I.97, R.99, S.105, Y.108, G.115, L.118, H.195, L.196, L.199, S.204, N.205
16 PLIP interactions:16 interactions with chain T,- Hydrophobic interactions: T:L.36, T:L.36, T:F.89, T:L.93, T:L.118, T:L.196, T:L.199, T:L.199
- Hydrogen bonds: T:S.34, T:S.105, T:N.205
- Salt bridges: T:H.96, T:R.99, T:R.99
- pi-Cation interactions: T:R.99
- Metal complexes: T:H.96
- 3 x PLX: (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL(Non-covalent)
PLX.12: 16 residues within 4Å:- Chain C: Y.37, T.40, T.43, V.47
- Chain D: F.14, T.17, F.20, A.21
- Chain H: I.222
- Chain I: I.225, A.228, L.235
- Chain K: D.417, F.442
- Ligands: PEE.4, PEE.14
10 PLIP interactions:1 interactions with chain D, 3 interactions with chain I, 4 interactions with chain C, 1 interactions with chain H, 1 interactions with chain K- pi-Cation interactions: D:F.20, C:Y.37
- Hydrophobic interactions: I:I.225, I:A.228, I:L.235, C:T.43, C:V.47, H:I.222
- Hydrogen bonds: C:T.44
- Salt bridges: K:D.417
PLX.17: 16 residues within 4Å:- Chain N: Y.37, T.40, T.43, T.44, V.47
- Chain O: F.14, R.15, T.17, F.20, A.21
- Chain T: L.231
- Chain V: F.442, L.444
- Ligands: PEE.19, CDL.25, PEE.26
8 PLIP interactions:1 interactions with chain V, 4 interactions with chain N, 2 interactions with chain O, 1 interactions with chain T- Salt bridges: V:D.417
- Hydrophobic interactions: N:T.40, N:T.43, N:V.47, O:A.21, T:L.231
- pi-Cation interactions: N:Y.37
- Hydrogen bonds: O:T.17
PLX.18: 7 residues within 4Å:- Chain R: R.8, L.12, W.16
- Chain V: R.344, S.348, W.443, R.445
2 PLIP interactions:1 interactions with chain R, 1 interactions with chain V- Hydrophobic interactions: R:W.16
- Hydrogen bonds: V:S.348
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, R. et al., Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2. Cell (2017)
- Release Date
- 2017-08-30
- Peptides
- Cytochrome b-c1 complex subunit 8: AL
Cytochrome b-c1 complex subunit Rieske, mitochondrial: BM
Cytochrome b-c1 complex subunit Rieske, mitochondrial: CN
Cytochrome b-c1 complex subunit 9: DO
Cytochrome b-c1 complex subunit 6, mitochondrial: EP
Cytochrome b-c1 complex subunit 7: FQ
Cytochrome b-c1 complex subunit 10: GR
Cytochrome c1, heme protein, mitochondrial: HS
Cytochrome b: IT
Cytochrome b-c1 complex subunit 2, mitochondrial: JU
Cytochrome b-c1 complex subunit 1, mitochondrial: KV - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AL
NB
BM
OC
CN
PD
DO
QE
EP
RF
FQ
SG
GR
TH
HS
UI
JT
VJ
KU
WK
LV
Y - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 9 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 6 x PEE: 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 2 x HEC: HEME C(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 3 x PLX: (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, R. et al., Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2. Cell (2017)
- Release Date
- 2017-08-30
- Peptides
- Cytochrome b-c1 complex subunit 8: AL
Cytochrome b-c1 complex subunit Rieske, mitochondrial: BM
Cytochrome b-c1 complex subunit Rieske, mitochondrial: CN
Cytochrome b-c1 complex subunit 9: DO
Cytochrome b-c1 complex subunit 6, mitochondrial: EP
Cytochrome b-c1 complex subunit 7: FQ
Cytochrome b-c1 complex subunit 10: GR
Cytochrome c1, heme protein, mitochondrial: HS
Cytochrome b: IT
Cytochrome b-c1 complex subunit 2, mitochondrial: JU
Cytochrome b-c1 complex subunit 1, mitochondrial: KV - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AL
NB
BM
OC
CN
PD
DO
QE
EP
RF
FQ
SG
GR
TH
HS
UI
JT
VJ
KU
WK
LV
Y - Membrane
-
We predict this structure to be a membrane protein.